Organisation: Novartis

These decisions are the first by national courts to interpret the CJEU’s preliminary ruling in Joined Cases C‑253/20 and C‑254/20.

13 June 2024

Trademark filings fell across five of six major registers in 2023, a new report by Clarivate reveals, but the results are more positive than they seem. 

30 May 2024

New report reveals that trademark filing activity has resumed growth in Australia after a significant decline in 2022, with foreign applications rising.

23 May 2024

Brand owners and law firm leaders offer their top tips for cost-effective enforcement, long-lasting licensing agreements and combatting social media fraud, at this year’s WTR Live: Brand Strategy Summit Europe. 

15 March 2024

USPTO Trademark Commissioner David Gooder sits down with WTR to outline key developments and challenges at the agency over the past 12 months. 

21 December 2023

WTR data analysis uncovers the companies filing the highest number of trademarks in-house – and those filing the highest number across the globe.

20 December 2023

The General Court confirmed that there was no likelihood of confusion between Novartis’ mark PASCELMO and the earlier mark PASCOE, both covering Class 5 goods.

27 October 2023

Data analysis reveals the companies with the largest trademark portfolios in the Association of Southeast Asian Nations – and evolving trends among the most active filers.

16 October 2023

Industry leaders share their insight on how to build and maintain a world-class brand at WTR’s high-end New York conference.

02 October 2023

In its attempts to crack down on malicious trademark registration, the CNIPA is applying Article 44(1) of the Trademark Law. In many cases, however, it is difficult to prove confusion among the relevant public.

14 September 2023